US2018153980A1PendingUtilityA1

Inactivated Bacterial Cell Formulation

63
Assignee: GANEDEN BIOTECH INCPriority: Apr 29, 2009Filed: Sep 11, 2017Published: Jun 7, 2018
Est. expiryApr 29, 2029(~2.8 yrs left)· nominal 20-yr term from priority
Inventors:Sean FarmerMichael A. BushDavid J. Keller
A61P 37/04A61P 29/00A61P 31/04A61P 31/12A61P 31/20A61P 35/00A61P 31/16A61K 2039/572A61K 35/74A61K 39/07A61P 11/00A61K 35/742A61K 2039/542A61K 2039/521
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to the use of lactic acid-producing bacteria to boost the immune system.

Claims

exact text as granted — not AI-modified
1 .- 14 . (canceled) 
     
     
         15 . A food or beverage composition comprising purified cell wall components of a  Bacillus coagulans  bacterium, the cell wall components being present in an immune system boosting amount. 
     
     
         16 . The composition of  claim 15 , wherein the purified cell wall components are dried or lyophilized. 
     
     
         17 . The composition of  claim 15 , wherein the cell wall components comprise a bioactive compound between 3 and 200 kDa. 
     
     
         18 . The composition of  claim 15 , wherein the cell wall components comprise a bioactive compound between 30 and 200 kDa. 
     
     
         19 . The composition of  claim 15 , wherein the cell wall components comprise a bioactive compound between 3 and 30 kDa. 
     
     
         20 . The composition of  claim 15 , wherein the cell wall components comprise a bioactive compound less than 3 kDa. 
     
     
         21 . The composition of  claim 15 , further comprising a supernatant of  Bacillus coagulans.    
     
     
         22 . The composition of  claim 21 , wherein the supernatant is dried supernatant. 
     
     
         23 . The composition of  claim 21 , wherein the supernatant comprises a bioactive compound between 30 and 200 kDa. 
     
     
         24 . The composition of  claim 21 , wherein the supernatant comprises a bioactive compound between 3 and 30 kDa. 
     
     
         25 . The composition of  claim 21 , wherein the supernatant comprises a bioactive compound less than 3 kDa. 
     
     
         26 . The composition of  claim 15 , wherein the  Bacillus coagulans  comprises  Bacillus coagulans  hammer strain Accession No. ATCC 31284, or a strain derived from  Bacillus coagulans  hammer strain Accession No. ATCC 31284. 
     
     
         27 . The composition of  claim 15 , wherein the  Bacillus coagulans  comprises GBI-30 strain ATCC Designation Number PTA-6086. 
     
     
         28 . The composition of  claim 15 , wherein the  Bacillus coagulans  comprises GBI-20 strain ATCC Designation Number PTA-6085. 
     
     
         29 . The composition of  claim 15 , wherein the  Bacillus coagulans  comprises GBI-40 strain ATCC Designation Number PTA-6087.

Join the waitlist — get patent alerts

Track US2018153980A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.